Novel trial designs for patients with gastrointestinal stromal tumor

Other authors

Institut Català de la Salut

[Serrano S] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Sarcoma Translational Research Program, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Rothschild S] The Life Raft Group, Wayne, USA. [Villacampa G] Oncology Data Science, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. The Institute of Cancer Research, London, UK. [Heinrich MC] Portland VA Health Care System and Knight Cancer Institute, Oregon Health & Science University, Portland. [George S] Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. [Blay JY] Department of Medical Oncology, Centre Léon Bérard, Lyon. Université Claude Bernard, Lyon, France. [Navarro V] Oncology Data Science, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2024-02-08T11:44:32Z

2024-02-08T11:44:32Z

2024-01

Abstract

Gastrointestinal stromal tumor


Tumor del estroma gastrointestinal


Tumor de l'estroma gastrointestinal


This work was funded in part by the FERO Foundation and the Asociación Española Contra el Cáncer [grant number AECC CLSEN20004SERR], both to CS. The general work of MCH has been supported by grants from the Department of Veterans Affairs [grant number 1 I01 BX005358-01A1] and the National Cancer Institute at the National Institutes of Health [grant number 1 R21 CA263400-01] and by philanthropic donations from the GIST Cancer Research Fund and the Jonathan David Foundation.

Document Type

Article


Published version

Language

English

Publisher

Elsevier

Related items

ESMO Open;9(1)

https://doi.org/10.1016/j.esmoop.2023.102218

Recommended citation

This citation was generated automatically.

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International

http://creativecommons.org/licenses/by-nc-nd/4.0/

This item appears in the following Collection(s)